Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Commingling

Is this change from the settlement? We were arguing before that TPL was not to commingle the patent portfolios. Is this express permission to do the opposite? I find it the most interesting part about the 10Q. I hope we see more information on the settlement and changes if any to the CA.

Share
New Message
Please login to post a reply